Skip to main content
Molecular Cancer logoLink to Molecular Cancer
. 2020 May 20;19:93. doi: 10.1186/s12943-020-01214-5

Correction to: Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy

Ke Xu 1, Dongkyoo Park 1, Andrew T Magis 2, Jun Zhang 3, Wei Zhou 4, Gabriel L Sica 5, Suresh S Ramalingam 4, Walter J Curran 1, Xingming Deng 1,
PMCID: PMC7238649  PMID: 32434536

Correction to: Mol Cancer (2019) 18:85

https://doi.org/10.1186/s12943-019-1012-4

Following the publication of the original article [1], the authors spotted error in Fig. 1C. The colony formation image of H1792 in control row was accidently placed the same image of H322. This is a mistake and has to be corrected. Now, the actual image of H1792 in control row is placed at H1792 spot in revised Fig. 1 (below). This correction does not change any conclusions made in the article. The authors apologize for this error and any confusion it may have caused.

graphic file with name 12943_2020_1214_Figa_HTML.jpg

Reference

  • 1.Xu K, Park D, Magis AT, Zhang J, Zhou W, Sica GL, Ramalingam SS, Curran WJ, Deng X. Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy. Mol Cancer. 2019;18:85. doi: 10.1186/s12943-019-1012-4. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Molecular Cancer are provided here courtesy of BMC

RESOURCES